Levetiracetam
Product Sizes
50 mg
£ POA
HY-B0106-50MG
100 mg
£ POA
HY-B0106-100MG
500 mg
£ POA
HY-B0106-500MG
10mM/1mL
£ POA
HY-B0106-10MM
About this Product
- SKU:
- HY-B0106
- Additional Names:
- UCB L059
- CAS Number:
- 102767-28-2
- Extra Details:
- Levetiracetam; an antiepileptic agent; binds the synaptic vesicle protein SV2A. Levetiracetam enhances Temozolomide effect on glioblastoma stem cell proliferation and apoptosis. Levetiracetam modulates HDAC levels ultimately silencing MGMT; thus increasing Temozolomide effectiveness. A chemosensitizer agent[1][2].
- Molecular Weight:
- 170.21
- Purity:
- 99.98
- References:
- [1]Bianca Maria Scicchitano, et al. Levetiracetam enhances the temozolomide effect on glioblastoma stem cell proliferation and apoptosis. Cancer Cell Int. 2018 Sep 10;18:136.|[2]Delia M Talos, et al. Antiepileptic effects of levetiracetam in a rodent neonatal seizure model. Pediatr Res. 2013 Jan;73(1):24-30.
- Research Area:
- Cancer; Neurological Disease
- Shipping Conditions:
- Ambient
- Storage Conditions:
- -20[o]C; 3 years; 4[o]C; 2 years (Powder)
- Type:
- Proteins, Peptides, Small Molecules & Other Biomolecules: Small Molecules
- Pathway:
- Epigenetics
